Print this page

Program

Back to the program overview

Monday, 8 June 2009

14:00 - 15:00 Oral session - Lung Cancer (Session Code: O1_P2)


  • Chairperson(s):

    Joost NUYTTENS(Rotterdam, The Netherlands)
    Weon-Kuu CHUNG(DAEJEON, Republic of Korea)


    14:00

    O1_P2 01 CHARLSON CO-MORBIDITY INDEX PREDICTS FOR MORTALITY AFTER STEREOTACTIC BODY RADIOTHERAPY FOR MEDICALLY INOPERABLE EARLY STAGE NON-SMALL CELL LUNG CANCER
    Neil Kopek(Aarhus,Denmark)



    14:10

    O1_P2 02 PERIPHERAL EARLY STAGE LUNG TUMORS TREATED WITH REAL-TIME TUMOR TRACKING DURING STEREOTACTIC RADIOTHERAPY: A 3 YEARS EXPERIENCE
    Joost Nuyttens(Rotterdam,The Netherlands)



    14:20

    O1_P2 03 STEREOTACTIC PROTON RADIOTHERAPY MAY OFFER REDUCED NORMAL LUNG EXPOSURE FOR PATIENTS WITH LOCALIZED NON-SMALL CELL LUNG CANCER WHO ARE CANDIDATES FOR PHOTON BASED STEREOTACTIC RADIOTHERAPY
    Soon Huh(Jacksonville,United States)



    14:30

    O1_P2 04 FOUR-DIMENSIONAL LUNG TUMOR TRACKING FOR CENTRAL TUMORS DURING STEREOTACTIC RADIOTHERAPY
    Joost Nuyttens(Rotterdam,The Netherlands)



    14:40

    O1_P2 05 THE CLINICAL EFFECT ANALYSIS OF BODY ROTATING GAMMA SYSTEM RADIOSURGERY FOR LUNG CANCER WITH SUPERIOR VENA CAVA SYNDROME
    Feng Shouxin(Xuzhou,China)



    14:50

    O1_P2 06 SHORT-TERM THERAPEUTIC EFFECTIVENESS OF BODY ROTATING GAMMA SYSTEM WITH CONCURRENT CHEMOTHERAPY IN PATIENTS WITH ADVANCED NSCLC
    Haiying Cao(Shenzhen,China)